Gene therapy and immunotherapy.
The 35th annual meeting of the American Society of Clinical Oncology (ASCO), held at the Georgia World Congress Center, was attended by 20,260 cancer clinicians, academics and research and pharmaceutical industry scientists. The meeting program consisted of a varied series of poster and poster discussion sessions, education sessions, oral abstract presentations, plenary sessions, 'meet the professor' sessions, special lectures and integrated symposia. Some of the main 'hot topics' included gene therapy, immunotherapy, biological therapy (including vaccines and antibodies), prostate cancer, signal transduction inhibitors, anti-angiogenesis agents and several novel therapies and approaches.